Ensign Peak Advisors’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
BBA
DGM
OAG
Ensign Peak Advisors's INSM Position: Q2 2026 in Review
Ensign Peak Advisors increased its Insmed (INSM) stake by 41% in Q2 2026, buying an estimated $24.6M and bringing the position to 702,951 shares worth $74.9M. The position accounts for 0.12% of the portfolio, ranked #154.
Ensign Peak Advisors first reported a position in INSM in Q4 2021 and has held it in 19 quarters since. The position peaked at $92.5M in Q3 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- Ensign Peak Advisors held 702,951 shares of Insmed worth $74.9M as of Q2 2026.
- Ensign Peak Advisors bought 203,195 Insmed shares in Q2 2026, an estimated $24.6M.
- Insmed made up 0.12% of Ensign Peak Advisors's portfolio in Q2 2026, its #154 holding.
- Ensign Peak Advisors first reported a position in Insmed in Q4 2021 and has held it in 19 quarters since.
- Ensign Peak Advisors's Insmed position peaked at $92.5M in Q3 2025.
- 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.